Search Results - Larratt, L.M

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Influence Of Comorbidities On Transplant Outcomes In Patients Aged 50 Years Or More After Myeloablative Conditioning Incorporating Fludarabine, Busulfan And ATG

    Influence Of Comorbidities On Transplant Outcomes In Patients Aged 50 Years Or More After Myeloablative Conditioning Incorporating Fludarabine, Busulfan And ATG by Elkourashy, S.A, Yang, M, Turner, R, Larratt, L.M, Brown, C.B, Bahlis, N.J, Savoie, L.M, Daly, A, Geddes, M, Storek, J, Zacarias, N, Duggan, P.R, Quinlan, D, Stewart, D, Russell, J.A

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Long Term Follow-Up of a Randomized Trial Comparing Response Adapted (RA), Non-Cross Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG)

    Long Term Follow-Up of a Randomized Trial Comparing Response Adapted (RA), Non-Cross Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantone... by Van der Jagt, Richard H., Robinson, K., Sheridan, D.P., Delage, R., Larratt, L.M., Yetisir, L., Wells, G.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG)

    A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide... by van der Jagt, Richard H.C., Robinson, K.S., Sheridan, D.P., Delage, R., Larratt, L.M., Yetisir, E., Wells, G.A.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Recurrent Epstein-Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma

    Recurrent Epstein-Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma by Larratt, L.M., Hamilton, M., Coupland, R., Preiksaitis, J.K.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: